RevaTis (Public limited company)

BE 0541.682.642 Active ●Aye, Rue de la Science 8, 6900 Marche-en-Famenne

RevaTis is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0541.682.642. It was founded on 06-11-2013. Its registered office is in Marche-en-Famenne. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2024 report 5.7 full-time equivalents. Its annual accounts for 2025 report equity of € 2 551 321 and a loss of € 620 715. Addrly gives it a financial health grade of D, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for 3 of its last 4 financial years.

Information last updated on 09-10-2026.

Company information

Status
Active
Enterprise number
BE 0541.682.642
VAT registered
Yes
Founded
06-11-2013
Latest accounts
2025
Employees
5.7 FTE
Region
Wallonia
Establishments
1
Filing record
On time 3 of 4 years
Peppol e-invoicing
Registered
Registered office
Aye, Rue de la Science 8, 6900 Marche-en-Famenne
Main activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE activities
21201 Fabrication de médicaments
46460 Commerce de gros de produits pharmaceutiques et médicaux
72101 Recherche-développement en biotechnologie

Key figures of RevaTis

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -620 715-137 %€ -262 021-18 %€ -222 319€ 48 252
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 2 551 321+3 %€ 2 475 530-10 %€ 2 737 550+10 %€ 2 487 369
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 4 115 014+13 %€ 3 638 405-5 %€ 3 833 017+9 %€ 3 521 865
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ 136 602-77 %€ 606 821+4 %€ 582 301-15 %€ 688 155
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
-5.7+2 %5.6-

Financial estimate

Financial health grade D, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
12 mandates on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity in Marche-en-Famenne.

CompanyTown
S.M.B. TECHNOLOGY 6900 Marche-en-Famenne
BELGIAN DIAGNOSTIC COMPANY 6900 Marche-en-Famenne
GALEPHAR M/F 6900 Marche-en-Famenne
ATB THERAPEUTICS 6900 Marche-en-Famenne
THYMOLUX 6900 Marche-en-Famenne
ORGENESIS SERVICES SRL 6900 Marche-en-Famenne
Looking for more information about RevaTis?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is RevaTis still active? Yes. The Crossroads Bank for Enterprises lists RevaTis as active.

What is the VAT number of RevaTis? The VAT number of RevaTis is BE 0541.682.642.

When was RevaTis founded? RevaTis was founded on 06-11-2013.

What is the address of RevaTis? The current registered office of RevaTis is Aye, Rue de la Science 8, 6900 Marche-en-Famenne.

When did RevaTis last file annual accounts? The latest annual accounts of RevaTis were filed on 28-07-2026.

Does RevaTis file its annual accounts on time? RevaTis filed its annual accounts within the legal deadline for 3 of its last 4 financial years. Late: 2024.

How many employees does RevaTis have? RevaTis employs 5.7 full-time equivalents according to its most recent annual accounts.

Is RevaTis financially healthy? Addrly gives RevaTis a financial health grade of D, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is RevaTis profitable? The annual accounts of RevaTis for 2025 show a loss of € 620 715.

What is the equity of RevaTis? The equity of RevaTis was € 2 551 321 at the close of the 2025 financial year.

Who are the directors of RevaTis? The annual accounts of RevaTis record 12 mandates. The names, roles and dates are visible with a free account.

Can RevaTis receive Peppol e-invoices? Yes. RevaTis is registered on the Peppol network and can receive structured electronic invoices.

What does RevaTis do? The main activity of RevaTis is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.

Sources

How Addrly builds and refreshes this data